Preliminary Results of a Phase II Trial of Panobinostat (LBH589) In Refractory Myelodysplastic Syndromes (MDS) PatientsIan W. Flinn, John D. Hainsworth, Eric Raefsky et al.|Blood|2010Cited by 8